The Efficacy of Huaiqihuang Granule in Children With Primary Nephrotic Syndrome

CompletedOBSERVATIONAL
Enrollment

1,507

Participants

Timeline

Start Date

November 16, 2017

Primary Completion Date

July 21, 2021

Study Completion Date

August 31, 2021

Conditions
Nephrotic Syndrome
Trial Locations (17)

100020

Children's Hospital Capital Institute Of Pediatrics, Beijing

Unknown

Harbin Children's Hospital, Harbin

The First Affiliated Hospital of Xinxiang Medical University, Weihui

Henan Children's Hospital, Zhengzhou

Benq Medical Center, Nanjing

Children's Hospital of Nanjing Medical University, Nanjing

Children's Hospital of Soochow University, Suzhou

Wuxi Children's Hospital, Wuxi

Xuzhou Children's Hospital, Xuzhou

Jiangxi Provincal Children's Hospital, Nanchang

The first Bethune Hospital of Jilin University, Changchun

General Hospital of Ningxia Medical University, Yinchuan

Children's Hospital of Shanxi, Taiyuan

Chengdu Women's and Children's Central Hospital, Chengdu

Urumqi first people's Hospital, Ürümqi

Children's Hospital of Chongqing Medical University, Chongqing

Tianjin Children's Hospital, Tianjin

All Listed Sponsors
collaborator

Capital Institute of Pediatrics, China

OTHER

lead

Qidong Gaitianli Medicines Co., Ltd

INDUSTRY

NCT03332420 - The Efficacy of Huaiqihuang Granule in Children With Primary Nephrotic Syndrome | Biotech Hunter | Biotech Hunter